- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.53 Å
- Oligo State
- homo-dimer
- Ligands
- 6 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.2: 4 residues within 4Å:- Chain A: N.78, T.80, H.81, T.306
No protein-ligand interaction detected (PLIP)NAG-NAG.4: 2 residues within 4Å:- Chain A: N.152, S.154
No protein-ligand interaction detected (PLIP)NAG-NAG.14: 4 residues within 4Å:- Chain B: N.78, T.80, H.81, T.306
No protein-ligand interaction detected (PLIP)NAG-NAG.16: 2 residues within 4Å:- Chain B: N.152, S.154
No protein-ligand interaction detected (PLIP)- 2 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN.6: 10 residues within 4Å:- Chain A: S.588, S.591, A.592, N.595, Q.697
- Chain B: L.67, H.69, E.233, Y.234, R.311
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:E.233, B:R.311, B:R.311, B:H.69
- Water bridges: B:H.69, B:R.311, B:L.67
NAG-NAG-BMA-MAN-MAN.18: 10 residues within 4Å:- Chain A: L.67, H.69, E.233, Y.234, R.311
- Chain B: S.588, S.591, A.592, N.595, Q.697
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:E.233, A:R.311, A:R.311, A:H.69
- Water bridges: A:H.69, A:R.311, A:L.67
- 2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.7: 4 residues within 4Å:- Chain A: W.203, N.416, F.522, Y.523
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:W.203, A:Y.523
- Hydrogen bonds: A:W.203, A:F.522
- Water bridges: A:N.416, A:Y.529, A:Y.529, A:Y.529, A:Y.529
NAG.19: 4 residues within 4Å:- Chain B: W.203, N.416, F.522, Y.523
9 PLIP interactions:9 interactions with chain B- Hydrophobic interactions: B:W.203, B:Y.523
- Hydrogen bonds: B:W.203, B:F.522
- Water bridges: B:N.416, B:Y.529, B:Y.529, B:Y.529, B:Y.529
- 4 x ZN: ZINC ION(Non-covalent)
ZN.8: 5 residues within 4Å:- Chain A: D.344, E.382, H.510
- Ligands: ZN.9, 9LZ.12
5 PLIP interactions:4 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:D.344, A:E.382, A:E.382, A:H.510, H2O.12
ZN.9: 6 residues within 4Å:- Chain A: H.334, D.344, E.381, E.382, D.410
- Ligands: ZN.8
5 PLIP interactions:4 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:H.334, A:D.344, A:D.410, A:D.410, H2O.12
ZN.20: 5 residues within 4Å:- Chain B: D.344, E.382, H.510
- Ligands: ZN.21, 9LZ.24
5 PLIP interactions:4 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:D.344, B:E.382, B:E.382, B:H.510, H2O.36
ZN.21: 6 residues within 4Å:- Chain B: H.334, D.344, E.381, E.382, D.410
- Ligands: ZN.20
5 PLIP interactions:4 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:H.334, B:D.344, B:D.410, B:D.410, H2O.36
- 2 x CA: CALCIUM ION(Non-covalent)
CA.10: 4 residues within 4Å:- Chain A: T.226, Y.229, E.390, E.393
5 PLIP interactions:5 interactions with chain A- Metal complexes: A:T.226, A:Y.229, A:E.390, A:E.390, A:E.393
CA.22: 4 residues within 4Å:- Chain B: T.226, Y.229, E.390, E.393
5 PLIP interactions:5 interactions with chain B- Metal complexes: B:T.226, B:Y.229, B:E.390, B:E.390, B:E.393
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 2 x 9LZ: (2~{S})-2-[[(2~{S})-6-[[(2~{S})-2-[[4-[[[(2~{S})-2-[[(2~{R})-2-[(6-fluoranylpyridin-3-yl)carbonylamino]-3-sulfo-propanoyl]amino]-3-sulfo-propanoyl]amino]methyl]phenyl]carbonylamino]-3-naphthalen-2-yl-propanoyl]amino]-1-oxidanyl-1-oxidanylidene-hexan-2-yl]carbamoylamino]pentanedioic acid(Non-covalent)
9LZ.12: 31 residues within 4Å:- Chain A: K.164, F.166, R.167, N.214, D.344, E.381, E.382, G.384, L.385, E.414, R.420, P.461, R.468, S.470, K.471, G.475, N.476, R.491, R.493, W.498, F.503, S.504, G.505, Y.506, Y.509, H.510, N.655, K.656, Y.657, A.658
- Ligands: ZN.8
29 PLIP interactions:29 interactions with chain A- Hydrophobic interactions: A:P.461, A:Y.506, A:Y.509, A:Y.657, A:Y.657, A:A.658
- Hydrogen bonds: A:N.214, A:R.420, A:R.420, A:R.468, A:K.471, A:G.475, A:G.475, A:N.476, A:N.655
- Water bridges: A:N.214, A:D.344, A:S.470, A:K.471, A:K.471, A:R.491, A:K.656
- Salt bridges: A:R.167, A:K.471, A:R.491, A:R.493, A:H.510, A:K.656
- pi-Stacking: A:Y.509
9LZ.24: 31 residues within 4Å:- Chain B: K.164, F.166, R.167, N.214, D.344, E.381, E.382, G.384, L.385, E.414, R.420, P.461, R.468, S.470, K.471, G.475, N.476, R.491, R.493, W.498, F.503, S.504, G.505, Y.506, Y.509, H.510, N.655, K.656, Y.657, A.658
- Ligands: ZN.20
29 PLIP interactions:29 interactions with chain B- Hydrophobic interactions: B:P.461, B:Y.506, B:Y.509, B:Y.657, B:Y.657, B:A.658
- Hydrogen bonds: B:N.214, B:R.420, B:R.420, B:R.468, B:K.471, B:G.475, B:G.475, B:N.476, B:N.655
- Water bridges: B:N.214, B:D.344, B:S.470, B:K.471, B:K.471, B:R.491, B:K.656
- Salt bridges: B:R.167, B:K.471, B:R.491, B:R.493, B:H.510, B:K.656
- pi-Stacking: B:Y.509
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Novakova, Z. et al., X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a urea based inhibitor PSMA 1027. To Be Published
- Release Date
- 2018-06-13
- Peptides
- Glutamate carboxypeptidase 2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.53 Å
- Oligo State
- homo-dimer
- Ligands
- 6 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x ZN: ZINC ION(Non-covalent)
- 2 x CA: CALCIUM ION(Non-covalent)
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 2 x 9LZ: (2~{S})-2-[[(2~{S})-6-[[(2~{S})-2-[[4-[[[(2~{S})-2-[[(2~{R})-2-[(6-fluoranylpyridin-3-yl)carbonylamino]-3-sulfo-propanoyl]amino]-3-sulfo-propanoyl]amino]methyl]phenyl]carbonylamino]-3-naphthalen-2-yl-propanoyl]amino]-1-oxidanyl-1-oxidanylidene-hexan-2-yl]carbamoylamino]pentanedioic acid(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Novakova, Z. et al., X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a urea based inhibitor PSMA 1027. To Be Published
- Release Date
- 2018-06-13
- Peptides
- Glutamate carboxypeptidase 2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A